BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 48 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,245 | -99.8% | 1,262,000 | +146.5% | 0.00% | – |
| Q2 2022 | $507,000 | -83.2% | 512,000 | -82.9% | 0.00% | -100.0% |
| Q1 2022 | $3,021,000 | +154.9% | 3,000,000 | +164.6% | 0.00% | +100.0% |
| Q3 2020 | $1,185,000 | +558.3% | 1,134,000 | +671.4% | 0.00% | – |
| Q2 2020 | $180,000 | -96.4% | 147,000 | -96.8% | 0.00% | -100.0% |
| Q4 2019 | $4,946,000 | +19.9% | 4,665,000 | +11.4% | 0.00% | 0.0% |
| Q3 2019 | $4,126,000 | +410.6% | 4,187,000 | +430.0% | 0.00% | +200.0% |
| Q1 2019 | $808,000 | -90.2% | 790,000 | -90.3% | 0.00% | -85.7% |
| Q2 2018 | $8,254,000 | +1746.5% | 8,171,000 | +1616.6% | 0.01% | – |
| Q1 2018 | $447,000 | -93.3% | 476,000 | -92.9% | 0.00% | -100.0% |
| Q4 2017 | $6,664,000 | +82.6% | 6,689,000 | +85.7% | 0.01% | +25.0% |
| Q3 2017 | $3,649,000 | – | 3,602,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERBACK ASSET MANAGEMENT LLC | 36,000,000 | $36,583,000 | 5.85% |
| Man Investments (CH) AG | 3,200,000 | $3,250,000 | 2.78% |
| Verde Servicos Internacionais S.A. | 11,000,000 | $11,165,000 | 2.06% |
| Jabre Capital Partners S.A. | 10,000,000 | $10,156,000 | 1.97% |
| LINDEN ADVISORS LP | 38,500,000 | $39,095,000 | 1.39% |
| Opera Trading Capital | 9,900,000 | $9,925,000 | 1.35% |
| Sonora Investment Management, LLC | 4,950,000 | $5,029,596,000 | 0.87% |
| CQS Cayman LP | 10,000,000 | $10,165,000 | 0.68% |
| Polar Asset Management Partners Inc. | 25,000,000 | $25,384,000 | 0.51% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 26,000,000 | $26,383,000 | 0.50% |